Company Filing History:
Years Active: 1994-1997
Title: Innovator Allen R. Schantz, II: Pioneering Interaction Systems in Biotechnologies
Introduction: Allen R. Schantz, II, based in Reston, Virginia, has made notable contributions to the field of biotechnology through his innovative inventions. With two patents to his name, Schantz focuses on creating interaction systems that utilize surfactant-stabilized dispersions for enhancing functional capabilities of antibodies and antibody fragments.
Latest Patents: Schantz's recent patents include:
1. **Interaction System Comprising a Surfactant-Stabilized Disperse Aqueous** - This invention outlines an interaction system featuring an antibody or antibody fragment that works effectively through a surfactant-stabilized microheterogeneous dispersion of aqueous phase in a water-immiscible medium. The aqueous phase includes a sufficient amount of the antibody or fragment in a functional state to enable necessary interactions.
2. **Interaction System Comprising a Surfactant-Stabilized Aqueous Phase** - Similar to his first patent, this system consists of an antibody or antibody fragment with functional capability, utilizing a surfactant-stabilized microheterogeneous dispersion of aqueous phase within a water-immiscible medium, designed to facilitate effective interactions with the functional state of the antibody or fragment.
Career Highlights: Allen R. Schantz, II is currently associated with Igen, Inc., where he plays a vital role in driving innovations in biotechnological solutions. His work emphasizes the enhancement of product efficacy through advanced interaction systems.
Collaborations: Throughout his career, Schantz has collaborated closely with colleagues, including Charles N. Durfor and Richard J. Bolin. These partnerships reflect a commitment to fostering innovation and advancing the capabilities of biotechnology.
Conclusion: With a strong focus on developing interaction systems that leverage antibody functionalities, Allen R. Schantz, II represents the forefront of innovation in biotechnology. His work at Igen, Inc., along with valuable collaborations, underscores his contributions to the field, making him a noteworthy inventor to follow in the coming years.